41
Congestive Heart Failure 3. Treatment March 2013 ghennersdorf DGK ESC SES 1 Medical Science Tanzania Cardiology Lectures Prof. Hennersdorf SES

Heart failure 2013 Therapy

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Heart failure 2013 Therapy

Congestive Heart Failure

3. Treatment

March 2013 ghennersdorf DGK ESC SES 1

Medical Science Tanzania Cardiology Lectures

Prof. Hennersdorf SES

Page 2: Heart failure 2013 Therapy

General signs and symptoms

March 2013 ghennersdorf DGK ESC SES 2

Page 3: Heart failure 2013 Therapy

Definition of Heart Failure CHF

• New York Heart Association (NYHA)– I no visible signs and symptoms– II signs and symptoms at high level exercise– III signs and symptoms at low level exercise– IV no physical exercise possible, bed rest

necessary

March 2013 ghennersdorf DGK ESC SES 3

Worldwide used as functional definition of CHF!

Page 4: Heart failure 2013 Therapy

Treatment Goals

March 2013 ghennersdorf DGK ESC SES 4

IV

III

II

I

??

??

??

HTX option

Main treatment goalfor chronic disease

Main treatment goalfor acute disease

Page 5: Heart failure 2013 Therapy

Therapeutic objectives

• Acute CHF– Treatment of life threat– Improvement of life quality

• Chronic CHF– Improvement of life quality– Reduction of Disability– Increase of longevity

March 2013 ghennersdorf DGK ESC SES 5

Adding life to years rather than years to life

Main approachVasodilation

Organ protectionVolume control

Page 6: Heart failure 2013 Therapy

Therapeutic options

March 2013 ghennersdorf DGK ESC SES 6

Acute Heart Failure

Page 7: Heart failure 2013 Therapy

Therapeutic options (ER, ICU)• Physical approach in cardiogenic pulmonary edema

– Oxygen delivery– Bed rest / upright position– Secure (central) venous line– Urinary catheter– Blood letting

• Drugs (iv administration)– Diuretics (short term, furosemide)– Digitalis (?; fast AF ?)– Thrombembolic prophylaxis (heparin; PTT necessary)

• Drugs orally (cave hypotension)– Nitroglycerine sublingually– Consider ACEI sublingually

March 2013 ghennersdorf DGK ESC SES 7

Page 8: Heart failure 2013 Therapy

Therapeutic options (cardiogenic shock)

• Volume expansion under hemodynamic control– Pulmonary artery cath– Arterial pressure line

• Mechanical assistance: IABP• Cathlab: PCI• Surgery: revascularization• Drugs

– Catecholamines: Dopamin, Dobutamin– Phosphodiesterase (PDE)-Inhibitors: Amrinone, Milrinone (not

evidence based)– Thrombembolic prophylaxis: heparine (PTT)– Fast acting diuretics

• Acid base control• Electrolyte contol (potassium)

March 2013 ghennersdorf DGK ESC SES 8

Page 9: Heart failure 2013 Therapy

Therapeutic options

March 2013 ghennersdorf DGK ESC SES 9

Chronic Heart Failure

Page 10: Heart failure 2013 Therapy

Evidence

March 2013 ghennersdorf DGK ESC SES 10

Page 11: Heart failure 2013 Therapy

Therapeutic challenge

March 2013 ghennersdorf DGK ESC SES 11

Systolic heart failure: mostly common in CHD and RHDDrugs and recommendations according to guidelines

Diastolic heart failure: mostly common in hypertensionLong term follow up dependent on treatment of underlying diseaseDrugs recommendations not yet established

Page 12: Heart failure 2013 Therapy

Therapeutic options

• First line recommendation: Prevention– Prevention of CHD, Hypertension, valvular

disease, infections– Information, home care, transmission of simple

behavior rules:• Hygiene and clean water supply• Motion: physical activity, limited sport action• Nutrition: salt restriction• Refrain smoking

March 2013 ghennersdorf DGK ESC SES 12

Page 13: Heart failure 2013 Therapy

Therapeutic options• Conservative

– RAS modification• ACE-I• AT1-receptor antagonists• Aldosterone antagonists (Eplerenone ®)

– beta-AR competition• Betablockers

– classical 3D options• Diuretics (fast acting, medium acting; cave potassium)• Diet• Digitalis (?) not first choice!

– Others: (Pulmonary artery Hypertension)• Bosentan • Sildenafil

March 2013 ghennersdorf DGK ESC SES 13

Avoid use of NSAIDs like COXIBs

Page 14: Heart failure 2013 Therapy

ß-Blockade in CHF

March 2013 ghennersdorf DGK ESC SES 14

Page 15: Heart failure 2013 Therapy

ß-Blockade in CHF

March 2013 ghennersdorf DGK ESC SES 15

Page 16: Heart failure 2013 Therapy

ß-Blockade in CHF

March 2013 ghennersdorf DGK ESC SES 16

Muscle cell; contractilityNENEE

Muscle cell; contractility

NENENENEEEE

Muscle cell; contractility

NENENENEEEE

Betablockade: receptor recovery,function improves

AR Reduction

AR Recovery

Reduction of adrenergic receptors AR

Page 17: Heart failure 2013 Therapy

ß-Blockade in CHF

March 2013 ghennersdorf DGK ESC SES 17

Recommended: ß1-selective drugs like metoprolol, bisoprolol+ vasodilatation: carvedilol, nevibolol

Page 18: Heart failure 2013 Therapy

Therapeutic options. ACE-I

• Trials– CONSENSUS 1987 Captopril– SOLVD 1999 Enalapril– SAVE 1992 Captopril– VHEFT 1991 Enalapril/Hydralazin– CIBIS III 2005 Enalapril/Bisoprolol

March 2013 ghennersdorf DGK ESC SES 18

Demonstrate highly significant improvement of survival in different stages of heart failure (II –IV): Evidence Class A - IA

Page 19: Heart failure 2013 Therapy

Dosage recommendations

March 2013 ghennersdorf DGK ESC SES 19

Page 20: Heart failure 2013 Therapy

Dosage recommendations

March 2013 ghennersdorf DGK ESC SES 20

Page 21: Heart failure 2013 Therapy

Improvement of HF in cardiac CXR

March 2013 ghennersdorf DGK ESC SES 21

before treatment after treatment

Page 22: Heart failure 2013 Therapy

Therapeutic options

• Surgical– Heart transplantation, bridging– Cardiomyoplasty

• Resynchronizing pacemaker therapy (CRT)• Stem cell replacement

March 2013 ghennersdorf DGK ESC SES 22

Page 23: Heart failure 2013 Therapy

Therapeutic options

• HTX– Surgically solved– Concomitant therapy problems (rejection) solved– Donor problems unsolved and will persist

March 2013 ghennersdorf DGK ESC SES 23

But: therapeutic choice for subsets of younger patients with severe symptoms mostly on

iv therapy and/or ICU care without chance to recover appropriately.

Bridging procedure desirable

Page 24: Heart failure 2013 Therapy

Heart transplantation HTX

March 2013 ghennersdorf DGK ESC SES 24

Page 25: Heart failure 2013 Therapy

Heart transplantation

March 2013 ghennersdorf DGK ESC SES 25

Page 26: Heart failure 2013 Therapy

Heart transplantation

March 2013 ghennersdorf DGK ESC SES 26

3rd september 1967

original OR theatreGroote Schuur HospitalCape Town SAR

Christian Neethling Barnard

Page 27: Heart failure 2013 Therapy

Artificial heart

March 2013 ghennersdorf DGK ESC SES 27

Heartmate® for bridging procedures

Page 28: Heart failure 2013 Therapy

Survival after HTX

March 2013 ghennersdorf DGK ESC SES 28

Page 29: Heart failure 2013 Therapy

Therapeutic options: cardiac resynchronization therapy CRT

March 2013 ghennersdorf DGK ESC SES 29

Page 30: Heart failure 2013 Therapy

Therapeutic options

March 2013 ghennersdorf DGK ESC SES 30

Page 31: Heart failure 2013 Therapy

Therapeutic options: resynchronization therapy

March 2013 ghennersdorf DGK ESC SES 31

Page 32: Heart failure 2013 Therapy

Therapeutic options: stem cells

March 2013 ghennersdorf DGK ESC SES 32

Page 33: Heart failure 2013 Therapy

Therapeutic challenge: home care

• Medication starts in the hospital• Medication continues in household enviroment, rural areas • Doctor‘s contacts rare• Patient‘s survey difficult.• Therefore: narrow control schedules concerning

– Nurse directed home care– Continuous medical education of both patient and personal

(nurses/doctors)– Outpatient visits– Establishing telemedical processes

March 2013 ghennersdorf DGK ESC SES 33

Page 34: Heart failure 2013 Therapy

Therapeutic home care options• Home care (nurse driven)

– Scheduled visits on regular basis (nurse, AMO)– Visits following questionnaire– Data acquisition and transmission

(telemedicine?)• Severity of symptoms• Daily activities ability• Controls

– Medication– Weight (listing by patient)– Blood pressure– other

March 2013 ghennersdorf DGK ESC SES 34

Page 35: Heart failure 2013 Therapy

CHF Questionnaire; example

March 2013 ghennersdorf DGK ESC SES 35

How do you feel since last visit? Scale of 10 ptsIn your opinion, are there main changes:

breathingweight gainUrinary outputpalpitation?

How do you think developed your personal daily activities (DAs)?

worsesamebetter

which kind of DAs is mostly impaired?homeleisureemployment

What about your medication:intake OK?complaints?self made changes?incompatibilty?wishes?

Suggestions?

Page 36: Heart failure 2013 Therapy

Heart Network

March 2013 ghennersdorf DGK ESC SES 36

Patient

Hospital

Home Care

OPD

District Hospital

Dispensary

Page 37: Heart failure 2013 Therapy

Heart Network: nurse

March 2013 ghennersdorf DGK ESC SES 37

+

Hospital

Nurse

home care

Page 38: Heart failure 2013 Therapy

Heart Network: Internet

March 2013 ghennersdorf DGK ESC SES 38

Patient data file, database: EPF*Access by authorized personal throughout the country

*electronic patient file

Page 39: Heart failure 2013 Therapy

Heart Network

• Telecardiology (telemedicine)– Electronic provision of data transmission– Generation of medical data in remote areas (rural)– Overcoming of doctors shortages – Secure transmission line– Targets:

• Hospital Centers• Home care physician• Home care nurse• Specialized medical call centers

March 2013 ghennersdorf DGK ESC SES 39

Page 40: Heart failure 2013 Therapy

Heart Network

March 2013 ghennersdorf DGK ESC SES 40

• Telemedical patient kit – Smartphone with Apps (Skype)– Balance– ECG device– Blood pressure device– Glukose test kit– Finger tip pulse oxymeter– Questionnaire

Page 41: Heart failure 2013 Therapy

The End

March 2013 ghennersdorf DGK ESC SES 41